Suppr超能文献

[用异丙肌苷治疗类风湿性关节炎。个人经验]

[Treatment of rheumatoid arthritis with isoprinosine. Personal experience].

作者信息

Bouvier M, Bonvoisin B, Lejeune E, Sidot C, Touraine J L, Touraine F

出版信息

Rev Rhum Mal Osteoartic. 1983 Oct;50(10):653-7.

PMID:6196834
Abstract

Twenty patients with classical or proved rheumatoid arthritis were treated with Isoprinosine. 13 patients received a dose of 25 mg/kg/day and 7 received a dose of 50 mg/kg/day, continuously for 2 months and then discontinuously, 5 days every fortnight. The series being treated with 25 mg/kg/day (7 patients) have received treatment for 12 months. No side effects have been observed; the only reason for ceasing treatment was its ineffectiveness (after at least 3 months of administration). The dosage of the associated anti-inflammatory drugs did not need to be increased, but neither was it decreased. The authors conclude that Isoprinosine is largely ineffective clinically, on laboratory tests and in terms of immunology, at least with the therapeutic protocols tested here.

摘要

20例典型或确诊的类风湿性关节炎患者接受了异丙肌苷治疗。13例患者接受25mg/kg/天的剂量,7例接受50mg/kg/天的剂量,持续治疗2个月,然后间断治疗,每两周停药5天。接受25mg/kg/天治疗的7例患者已接受了12个月的治疗。未观察到副作用;停止治疗的唯一原因是治疗无效(至少给药3个月后)。相关抗炎药物的剂量无需增加,但也未减少。作者得出结论,至少就此处测试的治疗方案而言,异丙肌苷在临床、实验室检查及免疫学方面基本无效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验